COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,796 Articles (22,527 medRxiv, 8,269 bioRxiv)

Most recent first Previous |  Page 1509: Articles 15081-15090  | Next

Modelling upper respiratory viral load dynamics of SARS-CoV-2
Challenger, J. D., Foo, C. Y., Wu, Y., Moradi Marjaneh, M., Liew, F., Thwaites, R. S., Okell, L. C., Cunnington, A. J.
10.1101/2021.05.01.21256182 — Posted: 2021-05-06
1H, 13C and 15N resonance assignment of the SARS-CoV-2 full-length nsp1 protein and its mutants reveals its unique secondary structure features in solution.
Agback, P., Agback, T., Frolova, E. I., Frolov, I., Dominguez, F.
10.1101/2021.05.05.442725 — Posted: 2021-05-05
Prior aerosol infection with lineage A SARS-CoV-2 variant protects hamsters from disease, but not reinfection with B.1.351 SARS-CoV-2 variant
Yinda, K. C., Port, J., Bushmaker, T., Fischer, R., Schulz, J., Holbrook, M., Shaia, C., de Wit, E., van Doremalen, N., Munster, V.
10.1101/2021.05.05.442780 — Posted: 2021-05-05
SARS CoV-2 variant B.1.617.1 is highly pathogenic in hamsters than B.1 variant
Yadav, P. D., Mohandas, S., Shete, A. M., Nyayanit, D. A., Gupta, N., Patil, D. Y., Sapkal, G. N., Potdar, V., Kadam, M., kumar, A., Kumar, S., Suryavanshi, D., Mote, C. S., Abraham, P., Panda, S., Bhargava, B.
10.1101/2021.05.05.442760 — Posted: 2021-05-05
ProLung™-budesonide Inhibits SARS-CoV-2 Replication and Reduces Lung Inflammation
Konduri, K. S., Pattisapu, R., Pattisapu, J., Konduri, G. G., Zwetchkenbaum, J., Roy, B., Barman, M., Frazier, A., Hurst, B. L., Duzgunes, N.
10.1101/2021.05.05.442779 — Posted: 2021-05-05
dPQL: a lossless distributed algorithm for generalized linear mixed model with application to privacy-preserving hospital profiling
Luo, C., Islam, M. N., Sheils, N. E., Buresh, J., Chen, Y.
10.1101/2021.05.03.21256561 — Posted: 2021-05-05
Emerging genetic diversity of SARS-CoV-2 RNA dependent RNA polymerase (RdRp) alters its B-cell epitopes
Kumar, S., Azad, G. K.
10.1101/2021.05.04.442686 — Posted: 2021-05-05
SARS-CoV-2 cell-to-cell infection is resistant to neutralizing antibodies
Kruglova, N., Siniavin, A. E., Gushchin, V. A., Mazurov, D.
10.1101/2021.05.04.442701 — Posted: 2021-05-05
Combination Respiratory Vaccine Containing Recombinant SARS-CoV-2 Spike and QuadrivalentSeasonal Influenza Hemagglutinin Nanoparticles with Matrix-M Adjuvant
Massare, M. J., Patel, N., Zhou, B., Maciejewski, S., Flores, R., Guebre-Xabier, M., Tian, J.-H., Portnoff, A. D., Fries, L., Shinde, V., Ellingsworth, L. R., Glenn, G., Smith, G.
10.1101/2021.05.05.442782 — Posted: 2021-05-05
A Call For Better Methodological Quality Of Reviews On Using Artificial Intelligence For COVID-19 Detection In Medical Imaging - An Umbrella Systematic Review
Jemioło, P., Storman, D., Orzechowski, P.
10.1101/2021.05.03.21256565 — Posted: 2021-05-05

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).